drugset
drugset / Trial / NCT02243319

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

NCT02243319 ↗

Phase 1 Completed 24 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the pharmacokinetic drug interactions between HGP1201 and HGP0904

Timeline

Start
2014-09
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified — —
Subject HGP1201 Unknown — —

Indications

No indication recorded.